Funding · Company
ReAlta Life Sciences, Inc.
Norfolk, VABiotech & Pharma
ReAlta Life Sciences, Inc. of Norfolk, VA has disclosed $77M across 3 Form D offerings filed with the SEC between Sep 13, 2023 and May 21, 2025.
$77M
Total disclosed
3
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$30M
Form D · May 21, 2025 ↗
Q2 2025
· target $30M
Filing details
HeadquartersNorfolk, VAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001752530Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →